APA

Bendell J. C., Varghese A. M., Hyman D. M., Bauer T. M., Pant S., Callies S., Lin J., Martinez R., Wickremsinhe E., Fink A., Wacheck V. & Moore K. N. (20191220). A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Bendell Johanna C, Varghese Anna M, Hyman David M, Bauer Todd M, Pant Shubham, Callies Sophie, Lin Ji, Martinez Ricardo, Wickremsinhe Enaksha, Fink Aaron, Wacheck Volker and Moore Kathleen N. 20191220. A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Bendell J. C., Varghese A. M., Hyman D. M., Bauer T. M., Pant S., Callies S., Lin J., Martinez R., Wickremsinhe E., Fink A., Wacheck V. and Moore K. N. (20191220). A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Bendell Johanna C, Varghese Anna M, Hyman David M, Bauer Todd M, Pant Shubham, Callies Sophie, Lin Ji, Martinez Ricardo, Wickremsinhe Enaksha, Fink Aaron, Wacheck Volker and Moore Kathleen N. A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20191220.